Mabpharm Ltd 02181.HK 價格預測與預測

首頁

股票

02181.HK

預測

MABPHARM-B (02181.HK)

Mabpharm Ltd

HK$0.51

休市： Feb 16, 12:00:00 HKT

關鍵數據

前收市價

$0.51

開盤價

$0.51

當日範圍

$0.51 - $0.51

52週區間

$0.25 - $0.94

交易量

平均成交量

89.7K

每股盈餘 (TTM)

-0.01

股息收益率

市值

$2.1B

什麼是 MABPHARM-B？

Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 383 full-time employees. The company went IPO on 2019-05-31. The Company’s main products include CMAB009 Enlituo (cetuximab β injection), CMAB007 Aomaishu (Omalizumab α for Injection), CMAB008 Leiting (infliximab for injection) and other products. The Company’s products are mainly used for colorectal cancer, asthma, urticaria, rheumatoid arthritis, ulcerative colitis in adults and other diseases. The firm is also engaged in the transfer of intellectual property. The firm mainly conducts its business in the domestic market.

功能特性

資源

市場

02181.HK 股價預測摘要

02181.HK stock price ended at $0.51 on 星期四, after rising 0.00%

On the latest trading day Feb 12, 2026, the stock price of 02181.HK rose by 0.00%, climbing from $0.51 to $0.51. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.51 and a high of $0.51. Alongside this price increase, trading volume also rose by 18.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, -- shares were traded, amounting to a market value of approximately $2.1B.

02181.HK 技術面訊號

技術面訊號摘要

購買訊號 2

中性訊號 1

賣出訊號 4

Strong Sell

Sell

Neutral

Buy

Strong Buy

02181.HK 目前顯示 2 個買入訊號與 4 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 --。整體而言，技術指標顯示中期後市趨勢為 Sell。

02181.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為02181.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

Mabpharm Ltd（02181.HK）價格

02181.HK 股價走勢圖